PTPN1 was associated with multiple active ingredients of SMB in survival analysis; studies had shown that the overexpression of PTPN1 in high-grade serous carcinoma might be a marker of better response to chemotherapy [47]. Here, PTPN1 is linked to serous adenocarcinoma.